nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.432	1	CiPCiCtD
Epirubicin—thyroid cancer—germ cell cancer	0.0656	0.18	CtDrD
Epirubicin—uterine cancer—germ cell cancer	0.0542	0.149	CtDrD
Epirubicin—bone cancer—germ cell cancer	0.0486	0.133	CtDrD
Epirubicin—pancreatic cancer—germ cell cancer	0.0429	0.118	CtDrD
Epirubicin—ovarian cancer—germ cell cancer	0.0429	0.118	CtDrD
Epirubicin—testicular cancer—germ cell cancer	0.0403	0.111	CtDrD
Epirubicin—peripheral nervous system neoplasm—germ cell cancer	0.0356	0.0977	CtDrD
Epirubicin—sarcoma—germ cell cancer	0.0343	0.094	CtDrD
Epirubicin—TOP2A—Etoposide—germ cell cancer	0.0328	0.284	CbGbCtD
Epirubicin—ABCC1—Dactinomycin—germ cell cancer	0.0322	0.279	CbGbCtD
Epirubicin—ABCC1—Vinblastine—germ cell cancer	0.0202	0.175	CbGbCtD
Epirubicin—ABCC1—Etoposide—germ cell cancer	0.0182	0.158	CbGbCtD
Epirubicin—ABCC1—Methotrexate—germ cell cancer	0.012	0.104	CbGbCtD
Epirubicin—CHD1—trigeminal ganglion—germ cell cancer	0.000646	0.0259	CbGeAlD
Epirubicin—CHD1—brainstem—germ cell cancer	0.000572	0.0229	CbGeAlD
Epirubicin—CHD1—retina—germ cell cancer	0.000552	0.0221	CbGeAlD
Epirubicin—CHD1—telencephalon—germ cell cancer	0.000507	0.0203	CbGeAlD
Epirubicin—CHD1—decidua—germ cell cancer	0.000481	0.0192	CbGeAlD
Epirubicin—DHCR7—trigeminal ganglion—germ cell cancer	0.000436	0.0174	CbGeAlD
Epirubicin—CHD1—gonad—germ cell cancer	0.000423	0.0169	CbGeAlD
Epirubicin—CHD1—uterus—germ cell cancer	0.000421	0.0168	CbGeAlD
Epirubicin—CHD1—pituitary gland—germ cell cancer	0.000413	0.0165	CbGeAlD
Epirubicin—YWHAG—trigeminal ganglion—germ cell cancer	0.0004	0.016	CbGeAlD
Epirubicin—CHD1—medulla oblongata—germ cell cancer	0.000399	0.016	CbGeAlD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—germ cell cancer	0.000393	0.314	CbGdCrCtD
Epirubicin—DHCR7—retina—germ cell cancer	0.000372	0.0149	CbGeAlD
Epirubicin—CHD1—adrenal gland—germ cell cancer	0.000369	0.0148	CbGeAlD
Epirubicin—CHD1—midbrain—germ cell cancer	0.000364	0.0146	CbGeAlD
Epirubicin—CHD1—bone marrow—germ cell cancer	0.000357	0.0143	CbGeAlD
Epirubicin—CHD1—spinal cord—germ cell cancer	0.000356	0.0142	CbGeAlD
Epirubicin—YWHAG—eye—germ cell cancer	0.000344	0.0138	CbGeAlD
Epirubicin—CHD1—female gonad—germ cell cancer	0.000344	0.0138	CbGeAlD
Epirubicin—DHCR7—telencephalon—germ cell cancer	0.000342	0.0137	CbGeAlD
Epirubicin—AURKA—gonad—germ cell cancer	0.000341	0.0137	CbGeAlD
Epirubicin—YWHAG—retina—germ cell cancer	0.000341	0.0137	CbGeAlD
Epirubicin—AURKA—uterus—germ cell cancer	0.000339	0.0136	CbGeAlD
Epirubicin—AURKA—pituitary gland—germ cell cancer	0.000333	0.0133	CbGeAlD
Epirubicin—DHCR7—skin of body—germ cell cancer	0.000327	0.0131	CbGeAlD
Epirubicin—CHD1—endocrine gland—germ cell cancer	0.00032	0.0128	CbGeAlD
Epirubicin—CHD1—head—germ cell cancer	0.000316	0.0126	CbGeAlD
Epirubicin—YWHAG—telencephalon—germ cell cancer	0.000314	0.0126	CbGeAlD
Epirubicin—CHD1—testis—germ cell cancer	0.000305	0.0122	CbGeAlD
Epirubicin—PLA2G4A—trigeminal ganglion—germ cell cancer	0.000298	0.0119	CbGeAlD
Epirubicin—YWHAG—decidua—germ cell cancer	0.000298	0.0119	CbGeAlD
Epirubicin—AURKA—adrenal gland—germ cell cancer	0.000297	0.0119	CbGeAlD
Epirubicin—AURKA—bone marrow—germ cell cancer	0.000288	0.0115	CbGeAlD
Epirubicin—DHCR7—gonad—germ cell cancer	0.000286	0.0114	CbGeAlD
Epirubicin—CHD1—cerebellum—germ cell cancer	0.000282	0.0113	CbGeAlD
Epirubicin—AURKA—Teniposide—Etoposide—germ cell cancer	0.000279	0.223	CbGdCrCtD
Epirubicin—DHCR7—pituitary gland—germ cell cancer	0.000279	0.0111	CbGeAlD
Epirubicin—AURKA—female gonad—germ cell cancer	0.000277	0.0111	CbGeAlD
Epirubicin—DHCR7—medulla oblongata—germ cell cancer	0.000269	0.0108	CbGeAlD
Epirubicin—YWHAG—gonad—germ cell cancer	0.000262	0.0105	CbGeAlD
Epirubicin—YWHAG—uterus—germ cell cancer	0.00026	0.0104	CbGeAlD
Epirubicin—AURKA—endocrine gland—germ cell cancer	0.000258	0.0103	CbGeAlD
Epirubicin—YWHAG—pituitary gland—germ cell cancer	0.000256	0.0102	CbGeAlD
Epirubicin—AURKA—head—germ cell cancer	0.000255	0.0102	CbGeAlD
Epirubicin—DHCR7—adrenal gland—germ cell cancer	0.000249	0.00996	CbGeAlD
Epirubicin—YWHAG—medulla oblongata—germ cell cancer	0.000247	0.00987	CbGeAlD
Epirubicin—AURKA—testis—germ cell cancer	0.000246	0.00985	CbGeAlD
Epirubicin—DHCR7—midbrain—germ cell cancer	0.000246	0.00983	CbGeAlD
Epirubicin—DHCR7—bone marrow—germ cell cancer	0.000241	0.00963	CbGeAlD
Epirubicin—DHCR7—spinal cord—germ cell cancer	0.00024	0.00959	CbGeAlD
Epirubicin—DHCR7—female gonad—germ cell cancer	0.000232	0.00929	CbGeAlD
Epirubicin—CHD1—brain—germ cell cancer	0.000229	0.00916	CbGeAlD
Epirubicin—YWHAG—adrenal gland—germ cell cancer	0.000228	0.00914	CbGeAlD
Epirubicin—YWHAG—midbrain—germ cell cancer	0.000225	0.00902	CbGeAlD
Epirubicin—PLA2G4A—decidua—germ cell cancer	0.000222	0.00888	CbGeAlD
Epirubicin—CHD1—lymph node—germ cell cancer	0.000221	0.00885	CbGeAlD
Epirubicin—YWHAG—bone marrow—germ cell cancer	0.000221	0.00884	CbGeAlD
Epirubicin—YWHAG—spinal cord—germ cell cancer	0.00022	0.0088	CbGeAlD
Epirubicin—DHCR7—endocrine gland—germ cell cancer	0.000216	0.00864	CbGeAlD
Epirubicin—DHCR7—head—germ cell cancer	0.000213	0.00853	CbGeAlD
Epirubicin—YWHAG—female gonad—germ cell cancer	0.000213	0.00852	CbGeAlD
Epirubicin—TOP2A—decidua—germ cell cancer	0.000211	0.00844	CbGeAlD
Epirubicin—DHCR7—testis—germ cell cancer	0.000206	0.00824	CbGeAlD
Epirubicin—YWHAG—endocrine gland—germ cell cancer	0.000198	0.00792	CbGeAlD
Epirubicin—YWHAG—head—germ cell cancer	0.000195	0.00782	CbGeAlD
Epirubicin—PLA2G4A—pituitary gland—germ cell cancer	0.000191	0.00763	CbGeAlD
Epirubicin—DHCR7—cerebellum—germ cell cancer	0.00019	0.00761	CbGeAlD
Epirubicin—YWHAG—testis—germ cell cancer	0.000189	0.00756	CbGeAlD
Epirubicin—AURKA—brain—germ cell cancer	0.000185	0.00739	CbGeAlD
Epirubicin—TOP2A—uterus—germ cell cancer	0.000184	0.00738	CbGeAlD
Epirubicin—PLA2G4A—medulla oblongata—germ cell cancer	0.000184	0.00736	CbGeAlD
Epirubicin—UGT2B7—endocrine gland—germ cell cancer	0.000179	0.00716	CbGeAlD
Epirubicin—AURKA—lymph node—germ cell cancer	0.000178	0.00714	CbGeAlD
Epirubicin—YWHAG—cerebellum—germ cell cancer	0.000174	0.00698	CbGeAlD
Epirubicin—UGT2B7—testis—germ cell cancer	0.000171	0.00682	CbGeAlD
Epirubicin—PLA2G4A—adrenal gland—germ cell cancer	0.00017	0.00682	CbGeAlD
Epirubicin—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.000169	0.135	CbGdCrCtD
Epirubicin—PLA2G4A—midbrain—germ cell cancer	0.000168	0.00673	CbGeAlD
Epirubicin—PLA2G4A—bone marrow—germ cell cancer	0.000165	0.00659	CbGeAlD
Epirubicin—PLA2G4A—spinal cord—germ cell cancer	0.000164	0.00657	CbGeAlD
Epirubicin—TOP2A—adrenal gland—germ cell cancer	0.000162	0.00648	CbGeAlD
Epirubicin—PLA2G4A—female gonad—germ cell cancer	0.000159	0.00636	CbGeAlD
Epirubicin—TOP2A—bone marrow—germ cell cancer	0.000157	0.00626	CbGeAlD
Epirubicin—DHCR7—brain—germ cell cancer	0.000154	0.00618	CbGeAlD
Epirubicin—TOP2A—female gonad—germ cell cancer	0.000151	0.00604	CbGeAlD
Epirubicin—DHCR7—lymph node—germ cell cancer	0.000149	0.00597	CbGeAlD
Epirubicin—PLA2G4A—endocrine gland—germ cell cancer	0.000148	0.00591	CbGeAlD
Epirubicin—YWHAG—brain—germ cell cancer	0.000142	0.00567	CbGeAlD
Epirubicin—PLA2G4A—testis—germ cell cancer	0.000141	0.00564	CbGeAlD
Epirubicin—YWHAG—lymph node—germ cell cancer	0.000137	0.00548	CbGeAlD
Epirubicin—ABCC1—telencephalon—germ cell cancer	0.000134	0.00536	CbGeAlD
Epirubicin—TOP2A—testis—germ cell cancer	0.000134	0.00535	CbGeAlD
Epirubicin—ABCC1—decidua—germ cell cancer	0.000127	0.00508	CbGeAlD
Epirubicin—ABCC1—uterus—germ cell cancer	0.000111	0.00444	CbGeAlD
Epirubicin—ABCC1—pituitary gland—germ cell cancer	0.000109	0.00436	CbGeAlD
Epirubicin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	0.000107	0.0852	CbGdCrCtD
Epirubicin—TOP2A—Podofilox—Etoposide—germ cell cancer	0.000107	0.0851	CbGdCrCtD
Epirubicin—TOP2A—Teniposide—Etoposide—germ cell cancer	0.000107	0.0851	CbGdCrCtD
Epirubicin—PLA2G4A—brain—germ cell cancer	0.000106	0.00423	CbGeAlD
Epirubicin—PLA2G4A—lymph node—germ cell cancer	0.000102	0.00409	CbGeAlD
Epirubicin—ABCC1—adrenal gland—germ cell cancer	9.74e-05	0.0039	CbGeAlD
Epirubicin—TOP2A—lymph node—germ cell cancer	9.7e-05	0.00388	CbGeAlD
Epirubicin—TOP2A—Vincristine—Vinblastine—germ cell cancer	9.13e-05	0.0729	CbGdCrCtD
Epirubicin—ABCC1—female gonad—germ cell cancer	9.08e-05	0.00364	CbGeAlD
Epirubicin—ABCC1—testis—germ cell cancer	8.06e-05	0.00322	CbGeAlD
Epirubicin—ABCC1—cerebellum—germ cell cancer	7.44e-05	0.00298	CbGeAlD
Epirubicin—ABCC1—brain—germ cell cancer	6.04e-05	0.00242	CbGeAlD
Epirubicin—ABCC1—lymph node—germ cell cancer	5.84e-05	0.00234	CbGeAlD
Epirubicin—Muscle spasms—Cisplatin—germ cell cancer	3.19e-05	0.000517	CcSEcCtD
Epirubicin—Angiopathy—Etoposide—germ cell cancer	3.17e-05	0.000513	CcSEcCtD
Epirubicin—Confusional state—Ifosfamide—germ cell cancer	3.17e-05	0.000513	CcSEcCtD
Epirubicin—Immune system disorder—Etoposide—germ cell cancer	3.16e-05	0.000511	CcSEcCtD
Epirubicin—Mediastinal disorder—Etoposide—germ cell cancer	3.15e-05	0.00051	CcSEcCtD
Epirubicin—Pain—Bleomycin—germ cell cancer	3.15e-05	0.000509	CcSEcCtD
Epirubicin—Oedema—Ifosfamide—germ cell cancer	3.14e-05	0.000509	CcSEcCtD
Epirubicin—Anaphylactic shock—Ifosfamide—germ cell cancer	3.14e-05	0.000509	CcSEcCtD
Epirubicin—Chills—Etoposide—germ cell cancer	3.14e-05	0.000508	CcSEcCtD
Epirubicin—Vision blurred—Cisplatin—germ cell cancer	3.13e-05	0.000507	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Methotrexate—germ cell cancer	3.13e-05	0.000506	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	3.13e-05	0.000506	CcSEcCtD
Epirubicin—Asthenia—Vinblastine—germ cell cancer	3.12e-05	0.000506	CcSEcCtD
Epirubicin—Infection—Ifosfamide—germ cell cancer	3.12e-05	0.000506	CcSEcCtD
Epirubicin—Alopecia—Etoposide—germ cell cancer	3.09e-05	0.0005	CcSEcCtD
Epirubicin—Cerebrovascular accident—Methotrexate—germ cell cancer	3.09e-05	0.0005	CcSEcCtD
Epirubicin—Lethargy—Methotrexate—germ cell cancer	3.09e-05	0.0005	CcSEcCtD
Epirubicin—Nervous system disorder—Ifosfamide—germ cell cancer	3.08e-05	0.000499	CcSEcCtD
Epirubicin—Ill-defined disorder—Cisplatin—germ cell cancer	3.08e-05	0.000499	CcSEcCtD
Epirubicin—Thrombocytopenia—Ifosfamide—germ cell cancer	3.08e-05	0.000498	CcSEcCtD
Epirubicin—Anaemia—Cisplatin—germ cell cancer	3.07e-05	0.000497	CcSEcCtD
Epirubicin—Skin disorder—Ifosfamide—germ cell cancer	3.05e-05	0.000494	CcSEcCtD
Epirubicin—Hyperhidrosis—Ifosfamide—germ cell cancer	3.04e-05	0.000492	CcSEcCtD
Epirubicin—Feeling abnormal—Bleomycin—germ cell cancer	3.03e-05	0.000491	CcSEcCtD
Epirubicin—Osteoarthritis—Methotrexate—germ cell cancer	3.03e-05	0.00049	CcSEcCtD
Epirubicin—Anorexia—Ifosfamide—germ cell cancer	3e-05	0.000485	CcSEcCtD
Epirubicin—Malaise—Cisplatin—germ cell cancer	2.99e-05	0.000485	CcSEcCtD
Epirubicin—Decreased appetite—Dactinomycin—germ cell cancer	2.98e-05	0.000483	CcSEcCtD
Epirubicin—Diarrhoea—Vinblastine—germ cell cancer	2.98e-05	0.000483	CcSEcCtD
Epirubicin—Dysgeusia—Etoposide—germ cell cancer	2.98e-05	0.000482	CcSEcCtD
Epirubicin—Leukopenia—Cisplatin—germ cell cancer	2.97e-05	0.000481	CcSEcCtD
Epirubicin—Fatigue—Dactinomycin—germ cell cancer	2.96e-05	0.000479	CcSEcCtD
Epirubicin—Back pain—Etoposide—germ cell cancer	2.94e-05	0.000477	CcSEcCtD
Epirubicin—Hypotension—Ifosfamide—germ cell cancer	2.94e-05	0.000476	CcSEcCtD
Epirubicin—Pain—Dactinomycin—germ cell cancer	2.93e-05	0.000475	CcSEcCtD
Epirubicin—Muscle spasms—Etoposide—germ cell cancer	2.93e-05	0.000474	CcSEcCtD
Epirubicin—Urticaria—Bleomycin—germ cell cancer	2.92e-05	0.000473	CcSEcCtD
Epirubicin—Body temperature increased—Bleomycin—germ cell cancer	2.91e-05	0.000471	CcSEcCtD
Epirubicin—Dizziness—Vinblastine—germ cell cancer	2.88e-05	0.000466	CcSEcCtD
Epirubicin—Convulsion—Cisplatin—germ cell cancer	2.88e-05	0.000466	CcSEcCtD
Epirubicin—Mood swings—Methotrexate—germ cell cancer	2.87e-05	0.000464	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	2.86e-05	0.000464	CcSEcCtD
Epirubicin—Ataxia—Methotrexate—germ cell cancer	2.85e-05	0.000461	CcSEcCtD
Epirubicin—Myalgia—Cisplatin—germ cell cancer	2.83e-05	0.000458	CcSEcCtD
Epirubicin—Feeling abnormal—Dactinomycin—germ cell cancer	2.83e-05	0.000458	CcSEcCtD
Epirubicin—Paraesthesia—Ifosfamide—germ cell cancer	2.82e-05	0.000457	CcSEcCtD
Epirubicin—Ill-defined disorder—Etoposide—germ cell cancer	2.82e-05	0.000457	CcSEcCtD
Epirubicin—Anxiety—Cisplatin—germ cell cancer	2.82e-05	0.000456	CcSEcCtD
Epirubicin—Anaemia—Etoposide—germ cell cancer	2.81e-05	0.000455	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	2.81e-05	0.000455	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dactinomycin—germ cell cancer	2.81e-05	0.000454	CcSEcCtD
Epirubicin—Dyspnoea—Ifosfamide—germ cell cancer	2.8e-05	0.000454	CcSEcCtD
Epirubicin—Somnolence—Ifosfamide—germ cell cancer	2.79e-05	0.000453	CcSEcCtD
Epirubicin—Liver function test abnormal—Methotrexate—germ cell cancer	2.79e-05	0.000452	CcSEcCtD
Epirubicin—Discomfort—Cisplatin—germ cell cancer	2.79e-05	0.000452	CcSEcCtD
Epirubicin—Vomiting—Vinblastine—germ cell cancer	2.77e-05	0.000448	CcSEcCtD
Epirubicin—Malaise—Etoposide—germ cell cancer	2.74e-05	0.000444	CcSEcCtD
Epirubicin—Breast disorder—Methotrexate—germ cell cancer	2.73e-05	0.000443	CcSEcCtD
Epirubicin—Vertigo—Etoposide—germ cell cancer	2.73e-05	0.000443	CcSEcCtD
Epirubicin—Decreased appetite—Ifosfamide—germ cell cancer	2.73e-05	0.000443	CcSEcCtD
Epirubicin—Headache—Vinblastine—germ cell cancer	2.73e-05	0.000442	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	2.72e-05	0.000441	CcSEcCtD
Epirubicin—Leukopenia—Etoposide—germ cell cancer	2.72e-05	0.000441	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	2.71e-05	0.00044	CcSEcCtD
Epirubicin—Abdominal pain—Dactinomycin—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Body temperature increased—Dactinomycin—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Fatigue—Ifosfamide—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Anaphylactic shock—Cisplatin—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Oedema—Cisplatin—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Hypersensitivity—Bleomycin—germ cell cancer	2.71e-05	0.000439	CcSEcCtD
Epirubicin—Infection—Cisplatin—germ cell cancer	2.69e-05	0.000436	CcSEcCtD
Epirubicin—Pain—Ifosfamide—germ cell cancer	2.69e-05	0.000435	CcSEcCtD
Epirubicin—Constipation—Ifosfamide—germ cell cancer	2.69e-05	0.000435	CcSEcCtD
Epirubicin—Loss of consciousness—Etoposide—germ cell cancer	2.67e-05	0.000433	CcSEcCtD
Epirubicin—Nervous system disorder—Cisplatin—germ cell cancer	2.66e-05	0.00043	CcSEcCtD
Epirubicin—Cough—Etoposide—germ cell cancer	2.65e-05	0.00043	CcSEcCtD
Epirubicin—Thrombocytopenia—Cisplatin—germ cell cancer	2.65e-05	0.00043	CcSEcCtD
Epirubicin—Tachycardia—Cisplatin—germ cell cancer	2.65e-05	0.000428	CcSEcCtD
Epirubicin—Asthenia—Bleomycin—germ cell cancer	2.64e-05	0.000427	CcSEcCtD
Epirubicin—Convulsion—Etoposide—germ cell cancer	2.64e-05	0.000427	CcSEcCtD
Epirubicin—Skin disorder—Cisplatin—germ cell cancer	2.63e-05	0.000426	CcSEcCtD
Epirubicin—Hypertension—Etoposide—germ cell cancer	2.63e-05	0.000425	CcSEcCtD
Epirubicin—Hyperhidrosis—Cisplatin—germ cell cancer	2.62e-05	0.000424	CcSEcCtD
Epirubicin—Asthma—Methotrexate—germ cell cancer	2.62e-05	0.000424	CcSEcCtD
Epirubicin—Pruritus—Bleomycin—germ cell cancer	2.6e-05	0.000421	CcSEcCtD
Epirubicin—Feeling abnormal—Ifosfamide—germ cell cancer	2.59e-05	0.00042	CcSEcCtD
Epirubicin—Chest pain—Etoposide—germ cell cancer	2.59e-05	0.000419	CcSEcCtD
Epirubicin—Eosinophilia—Methotrexate—germ cell cancer	2.59e-05	0.000419	CcSEcCtD
Epirubicin—Nausea—Vinblastine—germ cell cancer	2.59e-05	0.000419	CcSEcCtD
Epirubicin—Anorexia—Cisplatin—germ cell cancer	2.58e-05	0.000418	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	2.57e-05	0.000417	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ifosfamide—germ cell cancer	2.57e-05	0.000416	CcSEcCtD
Epirubicin—Pancreatitis—Methotrexate—germ cell cancer	2.56e-05	0.000415	CcSEcCtD
Epirubicin—Discomfort—Etoposide—germ cell cancer	2.56e-05	0.000414	CcSEcCtD
Epirubicin—Hypotension—Cisplatin—germ cell cancer	2.53e-05	0.00041	CcSEcCtD
Epirubicin—Hypersensitivity—Dactinomycin—germ cell cancer	2.53e-05	0.000409	CcSEcCtD
Epirubicin—Confusional state—Etoposide—germ cell cancer	2.5e-05	0.000405	CcSEcCtD
Epirubicin—Urticaria—Ifosfamide—germ cell cancer	2.5e-05	0.000404	CcSEcCtD
Epirubicin—Body temperature increased—Ifosfamide—germ cell cancer	2.49e-05	0.000402	CcSEcCtD
Epirubicin—Abdominal pain—Ifosfamide—germ cell cancer	2.49e-05	0.000402	CcSEcCtD
Epirubicin—Pancytopenia—Methotrexate—germ cell cancer	2.48e-05	0.000402	CcSEcCtD
Epirubicin—Anaphylactic shock—Etoposide—germ cell cancer	2.48e-05	0.000402	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	2.47e-05	0.0004	CcSEcCtD
Epirubicin—Infection—Etoposide—germ cell cancer	2.47e-05	0.000399	CcSEcCtD
Epirubicin—Asthenia—Dactinomycin—germ cell cancer	2.46e-05	0.000399	CcSEcCtD
Epirubicin—Dysuria—Methotrexate—germ cell cancer	2.45e-05	0.000396	CcSEcCtD
Epirubicin—Neutropenia—Methotrexate—germ cell cancer	2.45e-05	0.000396	CcSEcCtD
Epirubicin—Paraesthesia—Cisplatin—germ cell cancer	2.43e-05	0.000394	CcSEcCtD
Epirubicin—Thrombocytopenia—Etoposide—germ cell cancer	2.43e-05	0.000394	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Methotrexate—germ cell cancer	2.43e-05	0.000394	CcSEcCtD
Epirubicin—Tachycardia—Etoposide—germ cell cancer	2.42e-05	0.000392	CcSEcCtD
Epirubicin—Dyspnoea—Cisplatin—germ cell cancer	2.42e-05	0.000391	CcSEcCtD
Epirubicin—Skin disorder—Etoposide—germ cell cancer	2.41e-05	0.000391	CcSEcCtD
Epirubicin—Hyperhidrosis—Etoposide—germ cell cancer	2.4e-05	0.000389	CcSEcCtD
Epirubicin—Photosensitivity reaction—Methotrexate—germ cell cancer	2.39e-05	0.000387	CcSEcCtD
Epirubicin—Anorexia—Etoposide—germ cell cancer	2.37e-05	0.000383	CcSEcCtD
Epirubicin—Decreased appetite—Cisplatin—germ cell cancer	2.36e-05	0.000382	CcSEcCtD
Epirubicin—Diarrhoea—Dactinomycin—germ cell cancer	2.35e-05	0.00038	CcSEcCtD
Epirubicin—Pneumonia—Methotrexate—germ cell cancer	2.35e-05	0.00038	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Cisplatin—germ cell cancer	2.34e-05	0.000379	CcSEcCtD
Epirubicin—Vomiting—Bleomycin—germ cell cancer	2.34e-05	0.000379	CcSEcCtD
Epirubicin—Infestation NOS—Methotrexate—germ cell cancer	2.33e-05	0.000378	CcSEcCtD
Epirubicin—Infestation—Methotrexate—germ cell cancer	2.33e-05	0.000378	CcSEcCtD
Epirubicin—Drowsiness—Methotrexate—germ cell cancer	2.33e-05	0.000378	CcSEcCtD
Epirubicin—Hypotension—Etoposide—germ cell cancer	2.32e-05	0.000376	CcSEcCtD
Epirubicin—Rash—Bleomycin—germ cell cancer	2.32e-05	0.000376	CcSEcCtD
Epirubicin—Pain—Cisplatin—germ cell cancer	2.32e-05	0.000375	CcSEcCtD
Epirubicin—Dermatitis—Bleomycin—germ cell cancer	2.32e-05	0.000375	CcSEcCtD
Epirubicin—Hypersensitivity—Ifosfamide—germ cell cancer	2.32e-05	0.000375	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	2.31e-05	0.000374	CcSEcCtD
Epirubicin—Renal failure—Methotrexate—germ cell cancer	2.29e-05	0.000371	CcSEcCtD
Epirubicin—Stomatitis—Methotrexate—germ cell cancer	2.27e-05	0.000368	CcSEcCtD
Epirubicin—Conjunctivitis—Methotrexate—germ cell cancer	2.27e-05	0.000367	CcSEcCtD
Epirubicin—Asthenia—Ifosfamide—germ cell cancer	2.26e-05	0.000365	CcSEcCtD
Epirubicin—Sweating—Methotrexate—germ cell cancer	2.24e-05	0.000362	CcSEcCtD
Epirubicin—Feeling abnormal—Cisplatin—germ cell cancer	2.23e-05	0.000362	CcSEcCtD
Epirubicin—Paraesthesia—Etoposide—germ cell cancer	2.23e-05	0.000361	CcSEcCtD
Epirubicin—Pruritus—Ifosfamide—germ cell cancer	2.22e-05	0.00036	CcSEcCtD
Epirubicin—Haematuria—Methotrexate—germ cell cancer	2.22e-05	0.00036	CcSEcCtD
Epirubicin—Dyspnoea—Etoposide—germ cell cancer	2.21e-05	0.000358	CcSEcCtD
Epirubicin—Somnolence—Etoposide—germ cell cancer	2.21e-05	0.000357	CcSEcCtD
Epirubicin—Hepatobiliary disease—Methotrexate—germ cell cancer	2.21e-05	0.000357	CcSEcCtD
Epirubicin—Epistaxis—Methotrexate—germ cell cancer	2.2e-05	0.000356	CcSEcCtD
Epirubicin—Nausea—Bleomycin—germ cell cancer	2.18e-05	0.000354	CcSEcCtD
Epirubicin—Vomiting—Dactinomycin—germ cell cancer	2.18e-05	0.000353	CcSEcCtD
Epirubicin—Agranulocytosis—Methotrexate—germ cell cancer	2.18e-05	0.000352	CcSEcCtD
Epirubicin—Rash—Dactinomycin—germ cell cancer	2.16e-05	0.00035	CcSEcCtD
Epirubicin—Decreased appetite—Etoposide—germ cell cancer	2.16e-05	0.00035	CcSEcCtD
Epirubicin—Diarrhoea—Ifosfamide—germ cell cancer	2.15e-05	0.000348	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Etoposide—germ cell cancer	2.14e-05	0.000347	CcSEcCtD
Epirubicin—Body temperature increased—Cisplatin—germ cell cancer	2.14e-05	0.000347	CcSEcCtD
Epirubicin—Fatigue—Etoposide—germ cell cancer	2.14e-05	0.000347	CcSEcCtD
Epirubicin—Pain—Etoposide—germ cell cancer	2.12e-05	0.000344	CcSEcCtD
Epirubicin—Constipation—Etoposide—germ cell cancer	2.12e-05	0.000344	CcSEcCtD
Epirubicin—Haemoglobin—Methotrexate—germ cell cancer	2.1e-05	0.000341	CcSEcCtD
Epirubicin—Haemorrhage—Methotrexate—germ cell cancer	2.09e-05	0.000339	CcSEcCtD
Epirubicin—Hepatitis—Methotrexate—germ cell cancer	2.09e-05	0.000339	CcSEcCtD
Epirubicin—Dizziness—Ifosfamide—germ cell cancer	2.08e-05	0.000337	CcSEcCtD
Epirubicin—Pharyngitis—Methotrexate—germ cell cancer	2.08e-05	0.000336	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—germ cell cancer	2.07e-05	0.000335	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—germ cell cancer	2.05e-05	0.000332	CcSEcCtD
Epirubicin—Feeling abnormal—Etoposide—germ cell cancer	2.05e-05	0.000331	CcSEcCtD
Epirubicin—Nausea—Dactinomycin—germ cell cancer	2.04e-05	0.00033	CcSEcCtD
Epirubicin—Gastrointestinal pain—Etoposide—germ cell cancer	2.03e-05	0.000329	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—germ cell cancer	2.02e-05	0.000327	CcSEcCtD
Epirubicin—Vomiting—Ifosfamide—germ cell cancer	2e-05	0.000324	CcSEcCtD
Epirubicin—Hypersensitivity—Cisplatin—germ cell cancer	2e-05	0.000323	CcSEcCtD
Epirubicin—Rash—Ifosfamide—germ cell cancer	1.98e-05	0.000321	CcSEcCtD
Epirubicin—Dermatitis—Ifosfamide—germ cell cancer	1.98e-05	0.000321	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—germ cell cancer	1.98e-05	0.000321	CcSEcCtD
Epirubicin—Urticaria—Etoposide—germ cell cancer	1.97e-05	0.000319	CcSEcCtD
Epirubicin—Abdominal pain—Etoposide—germ cell cancer	1.96e-05	0.000318	CcSEcCtD
Epirubicin—Body temperature increased—Etoposide—germ cell cancer	1.96e-05	0.000318	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—germ cell cancer	1.96e-05	0.000317	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—germ cell cancer	1.95e-05	0.000316	CcSEcCtD
Epirubicin—Asthenia—Cisplatin—germ cell cancer	1.94e-05	0.000315	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—germ cell cancer	1.94e-05	0.000315	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—germ cell cancer	1.9e-05	0.000308	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—germ cell cancer	1.89e-05	0.000306	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—germ cell cancer	1.89e-05	0.000306	CcSEcCtD
Epirubicin—Chills—Methotrexate—germ cell cancer	1.88e-05	0.000304	CcSEcCtD
Epirubicin—Nausea—Ifosfamide—germ cell cancer	1.87e-05	0.000302	CcSEcCtD
Epirubicin—Diarrhoea—Cisplatin—germ cell cancer	1.85e-05	0.0003	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—germ cell cancer	1.85e-05	0.0003	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—germ cell cancer	1.83e-05	0.000297	CcSEcCtD
Epirubicin—Hypersensitivity—Etoposide—germ cell cancer	1.83e-05	0.000296	CcSEcCtD
Epirubicin—Erythema—Methotrexate—germ cell cancer	1.82e-05	0.000295	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—germ cell cancer	1.82e-05	0.000295	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—germ cell cancer	1.78e-05	0.000289	CcSEcCtD
Epirubicin—Asthenia—Etoposide—germ cell cancer	1.78e-05	0.000288	CcSEcCtD
Epirubicin—Back pain—Methotrexate—germ cell cancer	1.76e-05	0.000285	CcSEcCtD
Epirubicin—Pruritus—Etoposide—germ cell cancer	1.76e-05	0.000284	CcSEcCtD
Epirubicin—Vomiting—Cisplatin—germ cell cancer	1.72e-05	0.000279	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—germ cell cancer	1.72e-05	0.000278	CcSEcCtD
Epirubicin—Rash—Cisplatin—germ cell cancer	1.71e-05	0.000277	CcSEcCtD
Epirubicin—Dermatitis—Cisplatin—germ cell cancer	1.71e-05	0.000276	CcSEcCtD
Epirubicin—Diarrhoea—Etoposide—germ cell cancer	1.7e-05	0.000275	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—germ cell cancer	1.69e-05	0.000274	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—germ cell cancer	1.68e-05	0.000273	CcSEcCtD
Epirubicin—Malaise—Methotrexate—germ cell cancer	1.64e-05	0.000266	CcSEcCtD
Epirubicin—Dizziness—Etoposide—germ cell cancer	1.64e-05	0.000266	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—germ cell cancer	1.64e-05	0.000265	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—germ cell cancer	1.63e-05	0.000264	CcSEcCtD
Epirubicin—Nausea—Cisplatin—germ cell cancer	1.61e-05	0.000261	CcSEcCtD
Epirubicin—Cough—Methotrexate—germ cell cancer	1.59e-05	0.000258	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—germ cell cancer	1.58e-05	0.000256	CcSEcCtD
Epirubicin—Vomiting—Etoposide—germ cell cancer	1.58e-05	0.000256	CcSEcCtD
Epirubicin—Rash—Etoposide—germ cell cancer	1.57e-05	0.000254	CcSEcCtD
Epirubicin—Dermatitis—Etoposide—germ cell cancer	1.56e-05	0.000253	CcSEcCtD
Epirubicin—Headache—Etoposide—germ cell cancer	1.56e-05	0.000252	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—germ cell cancer	1.55e-05	0.000251	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—germ cell cancer	1.55e-05	0.000251	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—germ cell cancer	1.55e-05	0.000251	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	1.54e-05	0.00025	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—germ cell cancer	1.53e-05	0.000248	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—germ cell cancer	1.5e-05	0.000243	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—germ cell cancer	1.49e-05	0.000241	CcSEcCtD
Epirubicin—Infection—Methotrexate—germ cell cancer	1.48e-05	0.000239	CcSEcCtD
Epirubicin—Nausea—Etoposide—germ cell cancer	1.47e-05	0.000239	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—germ cell cancer	1.46e-05	0.000236	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—germ cell cancer	1.46e-05	0.000236	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—germ cell cancer	1.44e-05	0.000234	CcSEcCtD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	1.44e-05	0.0765	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Methotrexate—germ cell cancer	1.44e-05	0.000233	CcSEcCtD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	1.43e-05	0.076	CbGpPWpGaD
Epirubicin—Anorexia—Methotrexate—germ cell cancer	1.42e-05	0.00023	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—germ cell cancer	1.39e-05	0.000225	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	1.36e-05	0.000219	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—germ cell cancer	1.35e-05	0.000218	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—germ cell cancer	1.34e-05	0.000216	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—germ cell cancer	1.33e-05	0.000215	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—germ cell cancer	1.32e-05	0.000214	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—germ cell cancer	1.31e-05	0.000212	CcSEcCtD
Epirubicin—Decreased appetite—Methotrexate—germ cell cancer	1.29e-05	0.000209	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—germ cell cancer	1.28e-05	0.000208	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—germ cell cancer	1.28e-05	0.000208	CcSEcCtD
Epirubicin—Pain—Methotrexate—germ cell cancer	1.27e-05	0.000206	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—germ cell cancer	1.23e-05	0.000198	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—germ cell cancer	1.22e-05	0.000197	CcSEcCtD
Epirubicin—Urticaria—Methotrexate—germ cell cancer	1.18e-05	0.000191	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—germ cell cancer	1.18e-05	0.00019	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—germ cell cancer	1.18e-05	0.00019	CcSEcCtD
Epirubicin—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	1.14e-05	0.0604	CbGpPWpGaD
Epirubicin—Hypersensitivity—Methotrexate—germ cell cancer	1.1e-05	0.000177	CcSEcCtD
Epirubicin—Asthenia—Methotrexate—germ cell cancer	1.07e-05	0.000173	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—germ cell cancer	1.05e-05	0.00017	CcSEcCtD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	1.04e-05	0.0552	CbGpPWpGaD
Epirubicin—Diarrhoea—Methotrexate—germ cell cancer	1.02e-05	0.000165	CcSEcCtD
Epirubicin—Dizziness—Methotrexate—germ cell cancer	9.83e-06	0.000159	CcSEcCtD
Epirubicin—Vomiting—Methotrexate—germ cell cancer	9.46e-06	0.000153	CcSEcCtD
Epirubicin—Rash—Methotrexate—germ cell cancer	9.38e-06	0.000152	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—germ cell cancer	9.37e-06	0.000152	CcSEcCtD
Epirubicin—Headache—Methotrexate—germ cell cancer	9.32e-06	0.000151	CcSEcCtD
Epirubicin—Nausea—Methotrexate—germ cell cancer	8.83e-06	0.000143	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NANOG—germ cell cancer	8.05e-06	0.0427	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	7.75e-06	0.0411	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	5.39e-06	0.0286	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—ALPL—germ cell cancer	5.02e-06	0.0266	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—SOX2—germ cell cancer	4.3e-06	0.0228	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	4.24e-06	0.0225	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—germ cell cancer	3.84e-06	0.0204	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—OXT—germ cell cancer	3.72e-06	0.0197	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—KITLG—germ cell cancer	3.64e-06	0.0193	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	3.58e-06	0.019	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—germ cell cancer	3.46e-06	0.0183	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	3.15e-06	0.0167	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.81e-06	0.0149	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—MYC—germ cell cancer	2.73e-06	0.0145	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—AVP—germ cell cancer	2.53e-06	0.0134	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	2.48e-06	0.0132	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—germ cell cancer	2.47e-06	0.0131	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—germ cell cancer	2.47e-06	0.0131	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—CD9—germ cell cancer	2.45e-06	0.013	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—germ cell cancer	2.24e-06	0.0119	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	2.07e-06	0.011	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	2.04e-06	0.0108	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—MYC—germ cell cancer	2e-06	0.0106	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	1.66e-06	0.00881	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	1.6e-06	0.00849	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—germ cell cancer	1.57e-06	0.00831	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SLC2A3—germ cell cancer	1.56e-06	0.00825	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SLC22A3—germ cell cancer	1.53e-06	0.00812	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	1.53e-06	0.00812	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—germ cell cancer	1.52e-06	0.00807	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	1.45e-06	0.00767	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—germ cell cancer	1.4e-06	0.00745	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.37e-06	0.00728	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—H2AFZ—germ cell cancer	1.37e-06	0.00726	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MYC—germ cell cancer	1.32e-06	0.00699	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CD9—germ cell cancer	1.26e-06	0.00668	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CRABP1—germ cell cancer	1.25e-06	0.00662	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MYC—germ cell cancer	1.16e-06	0.00616	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	1.16e-06	0.00615	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	1.12e-06	0.00595	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	1.09e-06	0.00576	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—germ cell cancer	1.08e-06	0.00574	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—germ cell cancer	1.05e-06	0.00556	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—H2AFZ—germ cell cancer	1.04e-06	0.0055	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	9.82e-07	0.00521	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	9.79e-07	0.00519	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—HRAS—germ cell cancer	9.57e-07	0.00507	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.5e-07	0.00503	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—germ cell cancer	9.13e-07	0.00484	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	8.98e-07	0.00476	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	8.92e-07	0.00473	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	8.85e-07	0.00469	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	8.12e-07	0.0043	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—germ cell cancer	8.04e-07	0.00426	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	7.64e-07	0.00405	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.59e-07	0.00402	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	7.26e-07	0.00385	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MYC—germ cell cancer	7.04e-07	0.00373	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.79e-07	0.00307	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—germ cell cancer	5.53e-07	0.00293	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC2A3—germ cell cancer	5.37e-07	0.00285	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC22A3—germ cell cancer	5.29e-07	0.0028	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—germ cell cancer	5.29e-07	0.0028	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC2A3—germ cell cancer	5.27e-07	0.00279	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC22A3—germ cell cancer	5.19e-07	0.00275	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC2A3—germ cell cancer	5.02e-07	0.00266	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.02e-07	0.00266	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—OXT—germ cell cancer	5.02e-07	0.00266	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.76e-07	0.00252	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—germ cell cancer	4.73e-07	0.00251	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	4.57e-07	0.00242	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CRABP1—germ cell cancer	4.31e-07	0.00229	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CRABP1—germ cell cancer	4.23e-07	0.00224	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC2A3—germ cell cancer	4.21e-07	0.00223	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC22A3—germ cell cancer	4.14e-07	0.0022	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.14e-07	0.0022	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.12e-07	0.00218	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—germ cell cancer	4.01e-07	0.00213	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—germ cell cancer	3.88e-07	0.00206	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—germ cell cancer	3.58e-07	0.0019	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AVP—germ cell cancer	3.44e-07	0.00182	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CRABP1—germ cell cancer	3.38e-07	0.00179	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—OXT—germ cell cancer	2.96e-07	0.00157	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	2.94e-07	0.00156	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF4—germ cell cancer	2.89e-07	0.00153	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	2.8e-07	0.00149	CbGpPWpGaD
Epirubicin—ABCC1—Disease—H2AFZ—germ cell cancer	2.58e-07	0.00137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF4—germ cell cancer	2.53e-07	0.00134	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—germ cell cancer	2.51e-07	0.00133	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KITLG—germ cell cancer	2.37e-07	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—H2AFZ—germ cell cancer	2.26e-07	0.0012	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KITLG—germ cell cancer	2.08e-07	0.0011	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—germ cell cancer	2.06e-07	0.00109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AVP—germ cell cancer	2.03e-07	0.00108	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—germ cell cancer	1.89e-07	0.001	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—germ cell cancer	1.81e-07	0.000958	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGFR3—germ cell cancer	1.76e-07	0.000934	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KIT—germ cell cancer	1.62e-07	0.000858	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGFR3—germ cell cancer	1.54e-07	0.000819	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIT—germ cell cancer	1.42e-07	0.000752	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—germ cell cancer	1.04e-07	0.00055	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—germ cell cancer	8.9e-08	0.000472	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—germ cell cancer	7.8e-08	0.000414	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—germ cell cancer	6.99e-08	0.000371	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—germ cell cancer	6.41e-08	0.00034	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—germ cell cancer	6.13e-08	0.000325	CbGpPWpGaD
